2012 (v1)
Publication
Introduction: An observational multicenter study was carried out in Italy, to evaluate the acceptability and safety of the new intradermal (ID) influenza vaccine (IntanzaR, Sanofi Pasteur SA, Lyon, France) among subjects aged ≥ 60 years, compared with that of other intramuscular (IM) influenza vaccines. Compliance with the use of the ID vaccine...
Uploaded on: April 14, 2023